Hot Features
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -23.4 | -6.35179153094 | 368.4 | 370 | 341.6 | 1008 | 356.10966078 | DE |
| 4 | -14.6 | -4.06006674082 | 359.6 | 379.6 | 341.6 | 853 | 361.31284275 | DE |
| 12 | -36 | -9.44881889764 | 381 | 383.8 | 331.2 | 903 | 358.89938576 | DE |
| 26 | -1.6 | -0.461627236007 | 346.6 | 420 | 331.2 | 984 | 371.9527293 | DE |
| 52 | 42.4 | 14.0118968936 | 302.6 | 420 | 271.6 | 942 | 339.0717355 | DE |
| 156 | 42 | 13.8613861386 | 303 | 420 | 271.6 | 917 | 336.83680864 | DE |
| 260 | 42 | 13.8613861386 | 303 | 420 | 271.6 | 917 | 336.83680864 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.